Username Password
S&P 500: 1,351.68 Change: +0.14%

GLAXOSMITHKLINE PLC (GSK)

Overview
Price 45.06
Price Change Today 0.00 (0.00%)
P&P rating Rating: 3
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $45.06
Daily Range $0.00 - $0.00
52-Week Range $36.39 - $46.50
Volume 0
chart
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Other Resources for GSK
zacks.com
Commentary
Zacks Blog: Speedy Review for Roche Drug
February 9, 2012
Zacks Blog: Amgen Upped to Outperform
February 8, 2012
Zacks Blog: Glaxo Misses Estimates by a Mile
February 8, 2012
Zacks Blog: Incivek Catalyst at Play for Vertex
February 3, 2012
Zacks Blog: Vivus' ED Drug Continues to Hold Up
January 18, 2012
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
 
Brokerage Analyst Recommendations
9 Brokerage Firms Covering GSK
 
  
Strong Buy
5
Buy
0
Hold
4
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.89
 
GSK Ratings:BUY  SELL  HOLD
GSK Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

50 Buy
0 Sell
 
Top Buy Analysis
BUY: GSK Rating: 3
Company: GLAXOSMITHKLINE PLC
Points: 10.38
Start Price: $33.46
Start Date: 05/28/2010 9:55 AM
adviceguy
adviceguy
P&P Score: 27.95
Recs:
#1 Quality
#2 Price

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.92 11/06/10 Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) latest holdings as of the close on June 30, 2010 4 11/15/10
AndrewGreenBull
97.65 02/03/10 XNPT—Volatility or Opportunity? 0
AndrewGreenBull
97.65 01/20/10 FDA Calendar Focus: XNPT 0
Zacks_Analysts
0.00 02/09/12 Speedy Review for Roche Drug - Analyst Blog 0
Zacks_Analysts
0.00 02/08/12 Amgen Upped to Outperform - Analyst Blog 0
Zacks_Analysts
0.00 02/08/12 Glaxo Misses Estimates by a Mile - Analyst Blog 0
Zacks_Analysts
0.00 02/03/12 Incivek Catalyst at Play for Vertex - Analyst Blog 0
Zacks_Analysts
0.00 01/18/12 Vivus' ED Drug Continues to Hold Up - Analyst Blog 0
Zacks_Analysts
0.00 01/18/12 Glaxo, Astex Call Off Agreement - Analyst Blog 0
Zacks_Analysts
0.00 01/12/12 Glaxo and Theravance Suffer Setback - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   ...  40  >>
Commentary
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $33.46
Points: +10.38
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $45.06
Points: -6.09
Created: 11/08/2011
buy

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $34.15
Points: +12.72
Created: 05/15/2010

Comments: 0 | Comment

dmb dmb
Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $39.49
Points: -8.58
Created: 02/02/2010

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $36.52
Points: -26.03
Created: 07/14/2009

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $37.82
Points: -22.57
Created: 10/21/2008

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $39.99
Points: -24.67
Created: 10/19/2008

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $44.50
Points: +0.42
Created: 02/21/2008

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $51.07
Points: -3.98
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 3
Start Price: $52.73
Points: -6.76
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
rtezanos 0.24 BUY One to Three Months 11/08/2011 $45.06 $44.99
(+1.31%)
-0.16% +5.94% -6.09 view
adviceguy 27.95 BUY Three to Six Months 05/28/2010 $33.46 $44.99
(+1.31%)
+34.46% +24.07% +10.38 view
dmb 0.25 BUY One to Three Months 05/15/2010 $34.15 $44.99
(+1.31%)
+31.74% +19.02% +12.72
Roshambo 1.22 BUY Week to a Month 02/02/2010 $39.49 $44.99
(+1.31%)
+13.93% +22.51% -8.58
odeway 10.68 BUY Week or Less 07/14/2009 $36.52 $44.99
(+1.31%)
+23.19% +49.22% -26.03
ZeroTolerance 78.43 BUY Three to Six Months 10/21/2008 $37.82 $44.99
(+1.31%)
+18.96% +41.53% -22.57
AtoZ 62.72 BUY Three to Six Months 10/19/2008 $39.99 $44.99
(+1.31%)
+12.50% +37.17% -24.67
derave 53.45 BUY Three to Six Months 02/21/2008 $44.50 $44.99
(+1.31%)
+1.10% +0.68% +0.42
MichaelEast1 60.01 BUY Six Months to a Year 01/01/2008 $51.07 $44.99
(+1.31%)
-11.91% -7.92% -3.98
webwatch11 27.37 BUY Six Months to a Year 01/01/2008 $52.73 $44.99
(+1.31%)
-14.68% -7.92% -6.76
Pages: [ 1 ]  2   3   4   5  >>
Sponsored Links